Skip to main content

Advertisement

Log in

Longitudinal Characterization of Depression and Mood States Beginning in Primary HIV Infection

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Though depression is known to frequently afflict those with chronic HIV, mood during the early course of HIV is not well characterized. In a prospective study we assessed mood during primary HIV infection [primary HIV infection (PHI), <1 year duration], its association with neuropsychological performance and markers of neurological disease, and its longitudinal course including effects of antiretroviral therapy (ART). The Beck Depression Inventory (BDI) and Profile of Mood States (POMS) subscales were longitudinally administered prior to and after ART in PHI subjects. This evaluation of mood was done concurrently with blood, cerebrospinal fluid (CSF) and neuropsychological [total z and global deficit score (GDS)] evaluation at each visit. Analysis employed Spearman’s rho, logistic regression, and linear mixed models. 47.7 % of the 65 men recruited at a median 3.5 months HIV duration met BDI criteria for clinical depression at baseline, classified as ‘mild’ (n = 11), ‘moderate’ (n = 11), or ‘severe’ (n = 9). Drug, alcohol, and depression history did not associate with BDI score. Proportional somatic-performance scores were worse than cognitive-affective scores (p = .0045). Vigor subscore of POMS was reduced compared to norms and correlated with total z (r = 0.33, p = 0.013) and GDS (r = −0.32, p = 0.016). BDI and POMS correlated with one another (r = 0.85, p < .0001), but not with CSF or plasma HIV RNA, WBC, albumin ratio or neopterin. Improvement was not observed in BDI and POMS over 330 total follow-up visits, even after initiation of ART. Depression was prevalent during PHI in our subjects, associated with abnormal somatic-performance and vigor scores. Neither neuropsychological performance nor disease biomarkers correlated with depressed mood. Mood indices did not improve over time in the presence of ART.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Braganca M, Palha A. Depression and neurocognitive performance in Portuguese patients infected with HIV. AIDS Behav. 2011;15(8):1879–87.

    Article  PubMed  Google Scholar 

  2. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Amc J Health System Pharm. 2000;57(4):376–86.

    CAS  Google Scholar 

  3. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001;158(5):725–30.

    Article  CAS  PubMed  Google Scholar 

  4. Rabkin J. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163–71.

    Article  PubMed  Google Scholar 

  5. Kalichman SC, Sikkema KJ, Somlai A. Assessing persons with human immunodeficiency virus (HIV) infection using the Beck Depression Inventory: disease processes and other potential confounds. J Pers Assess. 1995;64(1):86–100.

    Article  CAS  PubMed  Google Scholar 

  6. Rabkin JG, Goetz RR, Remien RH, Williams JB, Todak G, Gorman JM. Stability of mood despite HIV illness progression in a group of homosexual men. Am J Psychiatry. 1997;154(2):231–8.

    CAS  PubMed  Google Scholar 

  7. Burack JH, Barrett DC, Stall RD, Chesney MA, Ekstrand ML, Coates TJ. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993;270(21):2568–73.

    Article  CAS  PubMed  Google Scholar 

  8. Evans D, Ten Have T, Douglas S, et al. Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection. Am J Psychiatry. 2002;159(10):1752–9.

    Article  PubMed  Google Scholar 

  9. Bornstein RA, Pace P, Rosenberger P, et al. Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry. 1993;150(6):922–7.

    CAS  PubMed  Google Scholar 

  10. Gibbie T, Mijch A, Ellen S, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med. 2006;7(2):112–21.

    Article  CAS  PubMed  Google Scholar 

  11. Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–45.

    Article  PubMed  Google Scholar 

  12. Treisman G, Fishman M, Schwartz J, Hutton H, Lyketsos C. Mood disorders in HIV infection. Depress Anxiety. 1998;7(4):178–87.

    Article  CAS  PubMed  Google Scholar 

  13. Akincigil A, Wilson I, Walkup J, Siegel M, Huang C, Crystal S. Antidepressant treatment and adherence to antiretroviral medications among privately insured persons with HIV/AIDS. AIDS Behav. 2011;15(8):1819–28.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Walkup J, Wei W, Sambamoorthi U, Crystal S. Antidepressant treatment and adherence to combination antiretroviral therapy among patients with AIDS and diagnosed depression. Psychiatr Q. 2008;79(1):43–53.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the international antiviral society—USA panel. JAMA 2012;308(4):387–402.

    Google Scholar 

  16. Davis LE, Hjelle BL, Miller VE, et al. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992;42(9):1736–9.

    Article  CAS  PubMed  Google Scholar 

  17. Pilcher CD, Shugars DC, Fiscus SA, et al. HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS. 2001;15(7):837–45.

    Article  CAS  PubMed  Google Scholar 

  18. Spudich S, Gisslen M, Hagberg L, et al. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. J Infect Dis. 2011;204(5):753–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Peterson JHF, Pilcher C et al. Changes in neurocognitive performance from early HIV-1 infection to initiation of antiretroviral therapy. 19th CROI. Seattle, WA.

  20. Atkinson JH, Higgins J, Vigil O, et al. Psychiatric context of acute/early HIV infection. The NIMH multisite acute HIV infection study: IV. AIDS Behav. 2009;13(6):1061–7.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Zetola N, Pilcher C. Diagnosis and management of acute HIV infection. Infect Dis Clin North Am. 2007;21(1):19–48.

    Article  PubMed  Google Scholar 

  22. Hecht FM, Wellman R, Busch MP, et al. Identifying the early post-HIV antibody seroconversion period. J Infect Dis. 2011;204(4):526–33.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Lindback S, Thorstensson R, Karlsson AC, et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS. 2000;14(15):2333–9.

    Article  CAS  PubMed  Google Scholar 

  24. Little S, Frost SDW, Wong J, et al. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol. 2008;82(11):5510–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561.

    Article  CAS  PubMed  Google Scholar 

  26. McNair D, Lorr M, Droppleman L. Revised manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service; 1992.

    Google Scholar 

  27. Beck AT, Steer RA. BDI, Beck depression inventory: manual. San Antonio, Tex.; [New York]: Psychological Corp.; Harcourt Brace & Company; 1993.

  28. Spudich SS, Nilsson AC, Lollo ND, et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis. 2005;5(1):98.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Gisslen M, Hagberg L, Brew B, Cinque P, Price R, Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis. 2007;195(12):1774–8.

    Article  CAS  PubMed  Google Scholar 

  30. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the beck depression inventory. A review. Psychopathology. 1998;31(3):160–8.

    Article  CAS  PubMed  Google Scholar 

  31. Nyenhuis DL, Yamamoto C, Luchetta T, Terrien A, Parmentier A. Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol. 1999;55(1):79–86.

    Article  CAS  PubMed  Google Scholar 

  32. Von Giesen H-J, Bäcker R, Hefter H, Arendt G. Depression does not influence basal ganglia-mediated psychomotor speed in HIV-1 Infection. J Neuropsychiatry Clin Neurosci. 2001;13(1):88–94.

    Article  Google Scholar 

  33. Cysique LA, Deutsch R, Atkinson JH, et al. Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc. 2007;13(1):1–11.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We sincerely thank the participants who volunteered for these studies. We also thank the San Francisco General Hospital (SFGH)/University of California–San Francisco (UCSF) Clinical Research Center, staff at the ARI-UCSF Laboratory of Clinical Virology, and staff at UCSF Options and Magnet/San Francisco AIDS Foundation for their invaluable help. This study was funded by the following Grants: National Institutes of Health (Grants R01 MH081772, K23 MH074466, P30 AI027763, P01 AI071713 and M01 RR0008336)), Yale Medical School Summer Research Fellowship.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jessica A. Gold.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gold, J.A., Grill, M., Peterson, J. et al. Longitudinal Characterization of Depression and Mood States Beginning in Primary HIV Infection. AIDS Behav 18, 1124–1132 (2014). https://doi.org/10.1007/s10461-013-0688-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-013-0688-5

Keywords

Navigation